Ms Bronwen Williams B.Williams2@hull.ac.uk
Organic Disease masquerading as IBS: an RCT in primary care: The Lincolnshire Poacher Study (Promoting Optimal Assessment to Change Health and Engineer an Economic Revolution
People Involved
Miss Kerri Morris Kerri.Morris@hull.ac.uk
Dr Kathryn Date K.Date@hull.ac.uk
Professor Judith Cohen J.Cohen@hull.ac.uk
Director, Hull Health Trials Unit
Project Description
Irritable bowel syndrome (IBS) affects up to 1 in 5 people in Britain. IBS can have a huge impact on a sufferer’s daily activities, general wellbeing, and overall health. IBS often carries major financial implications because of time lost from work, the cost of attending GP appointments and prescriptions. Sufferers also often report substantial extra ongoing costs for things like over-the-counter medicines, incontinence pads, deodorants, extra lavatory paper and laundry. And IBS does not just affect sufferers, their work, family and friendships. Treating IBS costs the NHS much more than £100 million annually.
The National Institute for Health and Care Excellence (NICE) guides how tests and treatments for diseases should be used. For IBS they recommend that the diagnosis can be made if someone has typical symptoms and normal results from four blood tests. More detailed tests used by specialists, NICE says, are not needed.
Once IBS is diagnosed, NICE recommends lifestyle and dietary changes and/or medicines although they admit that the evidence that these things help is weak. Indeed, NICE acknowledges that when their recommended treatments are used, at least half of sufferers continue with long term troublesome symptoms. The problem is that “typical IBS symptoms” and four blood tests are an unreliable way to distinguish patients with true IBS from those with other conditions which cause symptoms similar to IBS.
Evidence suggests that most people with constant or intermittent diarrhoea diagnosed as IBS in fact have a different diagnosis which the NICE recommended tests do not pick up. Examples of very treatable, often missed diagnoses and the number of affected people include: Sensitivity to fat in diet; Abnormal digestion of sugars; Germs living in parts of the bowel where there should be no germs; Microscopic bowel inflammation; Pancreas gland working inadequately.
Project Acronym | The Lincolnshire Poacher Study |
---|---|
Status | Project Complete |
Funder(s) | National Institute for Health Research |
Value | £21,708.00 |
Project Dates | Jun 1, 2020 - Apr 30, 2023 |
You might also like
BREATHE: Breathlessness RElief AT HomE Apr 1, 2019 - Oct 31, 2021
A feasibility study to address this RQ:
Does a paramedic-administered short non-pharmacological complex breathlessness intervention improve breathlessness and reduce conveyance to ED for people with breathlessness crisis compared with usual pr...
Read More about BREATHE: Breathlessness RElief AT HomE.
LIPS: A prospective registry-based cohort study to monitor the diagnosis and management of acute leukaemia in pregnancy Jun 1, 2018 - Feb 28, 2022
Acute leukaemia (AL) is an aggressive but potentially curable cancer that can affect women of childbearing age. When a pregnancy is complicated by a diagnosis of AL, clinicians face a complex dilemma: to balance risking the mother’s survival through...
Read More about LIPS: A prospective registry-based cohort study to monitor the diagnosis and management of acute leukaemia in pregnancy.
Endoscopic vein harvesting - Research Support Funding Aug 1, 2022 - Jul 31, 2023
The long saphenous vein remains the most frequently used conduit for coronary artery bypass grafting. Traditionally, the harvesting of this conduit has been by open incision extending upwards from the ankle in the inner side of the leg up to the groi...
Read More about Endoscopic vein harvesting - Research Support Funding.
North of England Women’s Diet and ActivitY After Breast Cancer Trial (NEW DAY-ABC) Nov 5, 2019 - Sep 30, 2021
This project is part of a larger consortium which involves University of Northumbria at Newcastle; Sheffield Hallam, Newcastle Hospital NHS Foundation Trust; Sheffield NHS Trust; Universities of Newcastle and Dundee.
The aim for this p...
Read More about North of England Women’s Diet and ActivitY After Breast Cancer Trial (NEW DAY-ABC).
Pre-Operative Oncotype DX testing: A decision impact study (PRE-DX study) Jul 1, 2022 - Jun 30, 2024
Collaboration with Henry Cain, Newcastle on Tyne NHS Foundation Trust.
Newcastle will be research governance sponsor
Industry funded, investigator led study - to be funded by Exact Sciences